Medical devices, healthcare technology and the business of care
PMA approval · P800002

AVITENE MICROFIBRILLAR COLLAGEN HEMOSTAT NON-WOVEN WEB

C.R. Bard, Inc. · Decision date Oct 24, 1980

FDA DECISIONP800002

What did the FDA approve?

FDA records P800002 as an original PMA application. The recorded decision is approval, dated Oct 24, 1980.

An approval order statement is not included in the imported record. Open the FDA listing for the decision documents.

Regulatory pathway
Original PMA
Clinical specialty
General, Plastic Surgery
Decision date
Oct 24, 1980

FDA source record

Regulatory record facts

Identifier
P800002
Regulatory pathway
Premarket approval application
Product code
LMF
Decision code
APPR
Decision date
Oct 24, 1980
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Agent, absorbable hemostatic, collagen based.

Product code
LMF
FDA device class
3

FDA decision timeline

  1. P800002 received

    Application receipt date recorded by FDA.

  2. P800002 · FDA decision

    APPR

  3. P800002/S036 · Related supplement

    Avitene Microfibrillar Collagen Hemostat (MCH) Non-Woven Web Webber

Timeline entries are records held by MedtechLedger for P800002. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P800002

Product / regulatory recordCompanyPathwayDecision dateSource
C.R. Bard, Inc.PMA supplementSep 29, 2026FDA

Explore the linked device profile

Other records with product code LMF

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

C.R. Bard, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
160 New Boston St., Woburn, MA, 01801

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records